{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:32:25Z","timestamp":1793039545291,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"This work was supported by the National Key R&D Program of China","award":["2016YFC1303100"],"award-info":[{"award-number":["2016YFC1303100"]}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["15441905700"],"award-info":[{"award-number":["15441905700"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["15DZ1940502"],"award-info":[{"award-number":["15DZ1940502"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["12411950200"],"award-info":[{"award-number":["12411950200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Commission of Health and Family Planning","award":["2013ZYJB0202"],"award-info":[{"award-number":["2013ZYJB0202"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572548"],"award-info":[{"award-number":["81572548"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772770"],"award-info":[{"award-number":["81772770"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272882"],"award-info":[{"award-number":["81272882"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12967-018-1489-4","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T06:46:37Z","timestamp":1525157197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Postprandial increase in serum CA125 as a surrogate biomarker for early diagnosis of ovarian cancer"],"prefix":"10.1186","volume":"16","author":[{"given":"Zhuowei","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,1]]},"reference":[{"key":"1489_CR1","unstructured":"Cancer Research UK (CRUK). Ovarian cancer survival statistics. In: CRUK; 2014. \n                    http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/ovarian-cancer\/survival?_ga=2.160865204.863681909.1516283142-420538730.1516283142#heading-Three\n                    \n                  . Accessed 18 Jan 2018."},{"issue":"6 Suppl","key":"1489_CR2","doi-asserted-by":"publisher","first-page":"273S","DOI":"10.1016\/S0197-2456(00)00098-2","volume":"21","author":"PC Prorok","year":"2000","unstructured":"Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, et al. Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials. 2000;21(6 Suppl):273S\u2013309S.","journal-title":"Control Clin Trials"},{"issue":"4","key":"1489_CR3","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/uog.6444","volume":"34","author":"A Sokalska","year":"2009","unstructured":"Sokalska A, Timmerman D, Testa AC, Van Holsbeke C, Lissoni AA, Leone FP, et al. Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses. Ultrasound Obstet Gynecol. 2009;34(4):462\u201370.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"8","key":"1489_CR4","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/sj.bjc.6605011","volume":"100","author":"K Huhtinen","year":"2009","unstructured":"Huhtinen K, Suvitie P, Hiissa J, Junnila J, Huvila J, Kujari H, et al. Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts. Br J Cancer. 2009;100(8):1315\u20139.","journal-title":"Br J Cancer"},{"issue":"2","key":"1489_CR5","first-page":"249","volume":"75","author":"JT Soper","year":"1990","unstructured":"Soper JT, Hunter VJ, Daly L, Tanner M, Creasman WT, Bast RC. Preoperative serum tumor-associated antigen levels in women with pelvic masses. Obstet Gynecol. 1990;75(2):249\u201354.","journal-title":"Obstet Gynecol"},{"key":"1489_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fsurg.2014.00014","volume":"1","author":"M Zafrakas","year":"2014","unstructured":"Zafrakas M, Grimbizis G, Timologou A, Tarlatzis BC. Endometriosis and ovarian cancer risk: a systematic review of epidemiological studies. Front Surg. 2014;1:14. \n                    https:\/\/doi.org\/10.3389\/fsurg.2014.00014\n                    \n                  .","journal-title":"Front Surg"},{"issue":"4","key":"1489_CR7","doi-asserted-by":"publisher","first-page":"373.e1-9","DOI":"10.1016\/j.ajog.2009.11.029","volume":"202","author":"RT Greenlee","year":"2010","unstructured":"Greenlee RT, Kessel B, Williams CR, Riley TL, Ragard LR, Hartge P, et al. Prevalence, incidence, and natural history of simple ovarian cysts among women > age 55 years old in a large cancer screening trial. Am J Obstet Gynecol. 2010;202(4):373.e1-9.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"1489_CR8","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1002\/1097-0142(20011201)92:11<2837::AID-CNCR10093>3.0.CO;2-5","volume":"92","author":"C Haaften-Day van","year":"2001","unstructured":"van Haaften-Day C, Shen Y, Xu F, Yu Y, Berchuck A, Havrilesky LJ, et al. OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal. Cancer. 2001;92(11):2837\u201344.","journal-title":"Cancer"},{"issue":"8","key":"1489_CR9","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1515\/cclm-2011-0477","volume":"50","author":"S Yu","year":"2012","unstructured":"Yu S, Yang HJ, Xie SQ, Bao YX. Diagnostic value of HE4 for ovarian cancer: a meta-analysis. Clin Chem Lab Med. 2012;50(8):1439\u201346.","journal-title":"Clin Chem Lab Med"},{"issue":"13","key":"1489_CR10","first-page":"3695","volume":"63","author":"I Hellstr\u00f6m","year":"2003","unstructured":"Hellstr\u00f6m I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res. 2003;63(13):3695\u2013700.","journal-title":"Cancer Res"},{"issue":"4","key":"1489_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/jclinpath-2012-201031","volume":"66","author":"S Ferraro","year":"2013","unstructured":"Ferraro S, Braga F, Lanzoni M, Boracchi P, Biganzoli EM, Panteghini M. Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review. J Clin Pathol. 2013;66(4):273\u201381.","journal-title":"J Clin Pathol"},{"key":"1489_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/1471-2407-12-258","volume":"12","author":"F Li","year":"2012","unstructured":"Li F, Tie R, Chang K, Wang F, Deng S, Lu W, et al. Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis. BMC Cancer. 2012;12:258.","journal-title":"BMC Cancer"},{"issue":"3","key":"1489_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ygyno.2011.02.022","volume":"121","author":"F Jacob","year":"2011","unstructured":"Jacob F, Meier M, Caduff R, Goldstein D, Pochechueva T, Hacker N, et al. No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. Gynecol Oncol. 2011;121(3):487\u201391.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1489_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/107155769400100118","volume":"1","author":"I Konishi","year":"1994","unstructured":"Konishi I, Fendrick JL, Parmley TH, Quirk JG Jr, O\u2019Brien TJ. Epidermal growth factor enhances secretion of the ovarian tumor-associated cancer antigen CA125 from the human amnion WISH cell line. J Soc Gynecol Investig. 1994;1(1):89\u201396.","journal-title":"J Soc Gynecol Investig"},{"issue":"5","key":"1489_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10552-017-0867-1","volume":"28","author":"AN Minlikeeva","year":"2017","unstructured":"Minlikeeva AN, Freudenheim JL, Cannioto RA, Szender JB, Eng KH, Modugno F, et al. History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium. Cancer Causes Control. 2017;28(5):469\u201386.","journal-title":"Cancer Causes Control"},{"issue":"14","key":"1489_CR16","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1158\/0008-5472.CAN-12-3385","volume":"73","author":"H Reuveni","year":"2013","unstructured":"Reuveni H, Flashner-Abramson E, Steiner L, Makedonski K, Song R, Shir A, et al. Therapeutic destruction of insulin receptor substrates for cancer treatment. Cancer Res. 2013;73(14):4383\u201394.","journal-title":"Cancer Res"},{"issue":"12","key":"1489_CR17","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.7314\/APJCP.2015.16.12.4987","volume":"16","author":"S Otokozawa","year":"2015","unstructured":"Otokozawa S, Tanaka R, Akasaka H, Ito E, Asakura S, Ohnishi H, et al. Associations of serum isoflavone, adiponectin and insulin levels with risk for epithelial ovarian cancer: results of a case-control study. Asian Pac J Cancer Prev. 2015;16(12):4987\u201391.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"Suppl 4","key":"1489_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2337\/diab.31.4.S78","volume":"31","author":"S Sandler","year":"1982","unstructured":"Sandler S, Andersson A. Survival of intrasplenically implanted islets in mice with experimental insulitis and hyperglycemia. Diabetes. 1982;31(Suppl 4):78\u201383.","journal-title":"Diabetes"},{"key":"1489_CR19","volume-title":"Support vector machines and other Kernel-based learning methods","author":"J Shawe-Taylor","year":"2000","unstructured":"Shawe-Taylor J, Cristianini N. Support vector machines and other Kernel-based learning methods. Cambridge: Cambridge University Press; 2000."},{"key":"1489_CR20","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511543241","volume-title":"Radial basis functions: theory and implementations","author":"MD Buhmann","year":"2003","unstructured":"Buhmann MD. Radial basis functions: theory and implementations. Cambridge: Cambridge University Press; 2003."},{"issue":"6","key":"1489_CR21","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1074\/jbc.M806776200","volume":"284","author":"O Kaneko","year":"2009","unstructured":"Kaneko O, Gong L, Zhang J, Hansen JK, Hassan R, Lee B, et al. A binding domain on mesothelin for CA125\/MUC16. J Biol Chem. 2009;284(6):3739\u201349.","journal-title":"J Biol Chem"},{"issue":"1","key":"1489_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1476-4598-5-50","volume":"5","author":"JA Gubbels","year":"2006","unstructured":"Gubbels JA, Belisle J, Onda M, Rancourt C, Migneault M, Ho M, et al. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors. Mol Cancer. 2006;5(1):50.","journal-title":"Mol Cancer"},{"issue":"8","key":"1489_CR23","first-page":"676","volume":"93","author":"WS Biggs","year":"2016","unstructured":"Biggs WS, Marks ST. Diagnosis and management of adnexal masses. Am Fam Physician. 2016;93(8):676\u201381.","journal-title":"Am Fam Physician"},{"issue":"1","key":"1489_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ogc.2011.02.005","volume":"38","author":"LA Cicchiello","year":"2011","unstructured":"Cicchiello LA, Hamper UM, Scoutt LM. Ultrasound evaluation of gynecologic causes of pelvic pain. Obstet Gynecol Clin N Am. 2011;38(1):85\u2013114.","journal-title":"Obstet Gynecol Clin N Am"},{"issue":"1","key":"1489_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ygyno.2015.02.003","volume":"137","author":"S Mabuchi","year":"2015","unstructured":"Mabuchi S, Kuroda H, Takahashi R, Sasano T. The PI3K\/AKT\/mTOR pathway as a therapeutic target in ovarian cancer. Gynecol Oncol. 2015;137(1):173\u20139.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"1489_CR26","doi-asserted-by":"publisher","first-page":"8213","DOI":"10.3390\/ijms14048213","volume":"14","author":"ZC Dobbin","year":"2013","unstructured":"Dobbin ZC, Landen CN. The importance of the PI3K\/AKT\/MTOR pathway in the progression of ovarian cancer. Int J Mol Sci. 2013;14(4):8213\u201327.","journal-title":"Int J Mol Sci"},{"key":"1489_CR27","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609\u201315.","journal-title":"Nature"},{"issue":"1","key":"1489_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ygyno.2005.03.043","volume":"98","author":"K Shibata","year":"2005","unstructured":"Shibata K, Kajiyama H, Mizokami Y, Ino K, Nomura S, Mizutani S, et al. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia. Gynecol Oncol. 2005;98(1):11\u20138.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1489_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1515\/BC.2001.022","volume":"382","author":"FG Hanisch","year":"2001","unstructured":"Hanisch FG. O-glycosylation of the mucin type. Biol Chem. 2001;382(2):143\u20139.","journal-title":"Biol Chem"},{"issue":"7","key":"1489_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/glycob\/cwj110","volume":"16","author":"S Parry","year":"2006","unstructured":"Parry S, Hanisch FG, Leir SH, Sutton-Smith M, Morris HR, Dell A, et al. N-Glycosylation of the MUC1 mucin in epithelial cells and secretions. Glycobiology. 2006;16(7):623\u201334.","journal-title":"Glycobiology"},{"issue":"3","key":"1489_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.lungcan.2009.07.016","volume":"68","author":"R Hassan","year":"2010","unstructured":"Hassan R, Schweizer C, Lu KF, Schuler B, Remaley AT, Weil SC, et al. Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: implications for cancer therapy. Lung Cancer. 2010;68(3):455\u20139.","journal-title":"Lung Cancer"},{"issue":"17","key":"1489_CR32","doi-asserted-by":"publisher","first-page":"7272","DOI":"10.18632\/oncotarget.2370","volume":"5","author":"S Joshi","year":"2014","unstructured":"Joshi S, Kumar S, Choudhury A, Ponnusamy MP, Batra SK. Altered Mucins (MUC) trafficking in benign and malignant conditions. Oncotarget. 2014;5(17):7272\u201384.","journal-title":"Oncotarget"},{"issue":"2","key":"1489_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1600-0897.1991.tb00972.x","volume":"26","author":"H Mori","year":"1991","unstructured":"Mori H, Sawairi M, Nakagawa M, Itoh N, Wada K, Tamaya T. Peritoneal fluid interleukin-1 beta and tumor necrosis factor in patients with benign gynecologic disease. Am J Reprod Immunol. 1991;26(2):62\u20137.","journal-title":"Am J Reprod Immunol"},{"key":"1489_CR34","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1476-4598-9-118","volume":"9","author":"JA Belisle","year":"2010","unstructured":"Belisle JA, Horibata S, Jennifer GA, Petrie S, Kapur A, Andr\u00e9 S, et al. Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes. Mol Cancer. 2010;9:118.","journal-title":"Mol Cancer"},{"issue":"3","key":"1489_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1155\/2012\/309203","volume":"32","author":"N Mitic","year":"2012","unstructured":"Mitic N, Milutinovic B, Jankovic M. Assessment of sialic acid diversity in cancer- and non-cancer related CA125 antigen using sialic acid-binding Ig-like lectins (Siglecs). Dis Markers. 2012;32(3):187\u201394.","journal-title":"Dis Markers"},{"issue":"5","key":"1489_CR36","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/jlb.66.5.705","volume":"66","author":"J Munday","year":"1999","unstructured":"Munday J, Floyd H, Crocker PR. Sialic acid binding receptors (siglecs) expressed by macrophages. J Leukoc Biol. 1999;66(5):705\u201311.","journal-title":"J Leukoc Biol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1489-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-018-1489-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1489-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T20:11:36Z","timestamp":1556655096000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-018-1489-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1489"],"URL":"https:\/\/doi.org\/10.1186\/s12967-018-1489-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,1]]},"assertion":[{"value":"1 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"114"}}